Sven Genetech Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 22.98 Cr
- Company Age 25 Year, 13 Days
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 151.25 Cr
- Satisfied Charges ₹ 82.34 Cr
About Sven Genetech
Sven Genetech Limited (SGL) is a Public Limited Indian Non-Government Company incorporated in India on 03 February 2000 and has a history of 25 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 22.98 Cr.
The company currently has active open charges totaling ₹151.25 Cr. The company has closed loans amounting to ₹82.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasan Mandayam, Venkat Kalavakolanu, and Kyoganahalli Guha serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230TG2000PLC033456
-
Company No.
033456
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
03 Feb 2000
-
Date of AGM
07 Aug 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sven Genetech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Kalavakolanu
|
Managing Director | 20-Oct-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srinivasan Mandayam
|
Director | 24-Feb-2006 | Current |
|
Kyoganahalli Guha
|
Director | 22-Dec-2004 | Current |
Financial Performance of Sven Genetech.
Enhance accessibility to Sven Genetech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sven Genetech?
Unlock access to Sven Genetech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹151.25 Cr
₹82.34 Cr
Charges Breakdown by Lending Institutions
- Ifci Limited : 60.00 Cr
- State Bank Of India : 47.50 Cr
- Punjab National Bank : 17.25 Cr
- State Bank Of Bikaner & Jaipur : 12.00 Cr
- Canbank Factors Limited : 10.00 Cr
- Others : 4.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2011 | State Bank Of India | ₹47.50 Cr | Open |
| 04 Feb 2010 | Ifci Limited | ₹60.00 Cr | Open |
| 15 Dec 2009 | Punjab National Bank | ₹17.25 Cr | Open |
| 16 Feb 2009 | Kotak Mahindra Bank Limited | ₹2.00 Cr | Open |
| 13 Feb 2009 | Kotak Mahindra Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Sven Genetech?
Unlock and access historical data on people associated with Sven Genetech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sven Genetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sven Genetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
